Interviews Archives - Page 3 of 7

Interview with transhumanism leader Maria Konovalenko

July 6, 2015 / Professor Paul Knoepfler, Ph.D. / 21 Comments

The transhumanism movement has been garnering attention lately for a variety of views including embracing aspects of heritable human genetic modification. Earlier this year I interviewed geneticist and transhumanist, George Church. In this post I interview molecular biophysicist and transhumanist Maria Konovalenko. She is the program coordinator at the Science for Life Extension Foundation. In […]

Interview with transhumanism leader Maria Konovalenko Read More »

Interview with Bioheart CSO, Kristin Comella including on FDA

April 21, 2015 / Professor Paul Knoepfler, Ph.D. / 13 Comments

I invited the Chief Scientific Officer (CSO) of Bioheart, Kristin Comella, to do an interview after hearing some buzz that this could be a critical time for the company and that it might have been recently visited by the FDA. Note that Comella not just Bioheart CSO, but also the primary instructor for physician training in stem

Interview with Bioheart CSO, Kristin Comella including on FDA Read More »

Jennifer Doudna Interview on CRISPR, Human Gene Editing

April 14, 2015 / Professor Paul Knoepfler, Ph.D.

I’m doing a series of interviews with leaders in the field on human germline modification with the first interview in this series with George Church and today’s second in this series is a conversation I had with Dr. Jennifer Doudna, a pioneer in CRISPR-Cas9 technology. Doudna is a Professor in MCB and Chemistry as well

Jennifer Doudna Interview on CRISPR, Human Gene Editing Read More »

George Church on Germline Human Genetic Modification

March 9, 2015 / Professor Paul Knoepfler, Ph.D. / 17 Comments

I recently interviewed leading genomics scientist George Church on the ways that trends in genomics are changing our world. We also discussed the possibility of heritable human genetic modification. These days we more often call this “CRISPR babies.” His answers suggest that genomics and gene editing are poised to radically change our world. They could literally

George Church on Germline Human Genetic Modification Read More »

ViaCyte CEO Laikind Interview: Trial Update, Melton, & Future

March 2, 2015 / Professor Paul Knoepfler, Ph.D.

VC-01-post-implant-final1-e1503703572933, viacyte

It’s been exciting to watch the recent developments in using stem cells as the basis for treatments for Type I Diabetes. One of the major players in this arena is the privately-held company, ViaCyte. In this post, I interview ViaCyte President and CEO, Paul Laikind. The topics include their VC-01 product, the Encaptra device, an update on

ViaCyte CEO Laikind Interview: Trial Update, Melton, & Future Read More »

Stemedica reply to Olbermann interview on Gordie Howe

January 24, 2015 / Professor Paul Knoepfler, Ph.D. / 9 Comments

The stem cell company Stemedica along with Mexican partner Novastem conducted a stem cell intervention on hockey legend Gordie Howe, who had suffered strokes in 2014. This situation has sparked a lot of discussion and media attention including a recent interview with Stemedica leadership on the Keith Olbermann show on ESPN. For balance and fairness

Stemedica reply to Olbermann interview on Gordie Howe Read More »

Olbermann Puff Interview on Stemedica & Gordie Howe

January 22, 2015 / Professor Paul Knoepfler, Ph.D. / 22 Comments

The stem cell company Stemedica has made a name for itself in the media lately through hockey legend Gordie Howe, who received a non-FDA approved stem cell “treatment” in Mexico via Stemedica and its partner, Novastem. Howe, known as Mr. Hockey, had several strokes in late 2014 and his health was declining. Stemedica and Novastem

Olbermann Puff Interview on Stemedica & Gordie Howe Read More »

Austen Heinz of Cambrian Genomics Interview: GMO creatures & people

January 14, 2015 / Professor Paul Knoepfler, Ph.D. / 5 Comments

What’s Cambrian Genomics? With rapid advances in genomics, gene editing, and methods to reproduce life in the lab such as cloning, today creating genetically modified organisms (GMOs) has never been easier. While there have been of course loads of discussions of GMOs in the past, we are entering a new era of what one might

Austen Heinz of Cambrian Genomics Interview: GMO creatures & people Read More »

Horwitz Interview Zooms in on Allen Cell Institute: the GoogleMaps of Cells

January 9, 2015 / Professor Paul Knoepfler, Ph.D.

One of the most exciting developments in the biomedical sciences in 2014 was the announcement of the new Allen Institute for Cell Science. This new institute, which will be focused on cell biology, received $100 million in funding from high-tech pioneer and philanthropist, Paul Allen. I am very curious about how the institute will tackle cell

Horwitz Interview Zooms in on Allen Cell Institute: the GoogleMaps of Cells Read More »

Radical Vision for CIRM Future: Interview with New Prez Mills

December 5, 2014 / Professor Paul Knoepfler, Ph.D.

Change is in the air for the California stem cell agency, CIRM. It has a new President, Randy Mills, and CIRM is soon going to be like a new agency too. I recently did an interview with Mills that illuminates some of the big changes that are imminent. I also asked him what his favorite

Radical Vision for CIRM Future: Interview with New Prez Mills Read More »

Interviews

Subscribe to Our Newsletter